2025 annual financial data
Telomir Pharmaceuticals 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -10,538,849 USD and net income was -10,413,205 USD.
Operating cash flow was -3,688,188 USD.
Get free Telomir Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,538,849 USD
- Net income
- -10,413,205 USD
- Operating cash flow
- -3,688,188 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Telomir Pharmaceuticals financial years